Centuple Global Ltd. Stock price: Live updates

₹45.69

2.72% (1.21)

Market Cap

₹25 Cr.

P/E

12.18

Key Ratios

Edit Ratio's

Market cap

25.00 Cr

12.18

Prom Holding

ROE (%)

4.55

ROCE (%)

9.42

Div Yield (%)

Sales

294 Cr

OPM (%)

0.93 %

Debt to Equity

Institutions

8.59 %

Individual < 2 lac

31.35 %

No. of Shareholders

2,457

Edit Ratio's

About

Rubra Medicaments Ltd was Incrporated in the year of 1991. The company is in the business acti… Read more

Low

52W Range

High

144

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

2 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Promoter Holding

Promoter has not sold any shares in the last 90 days
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Revenue Recognition

Unable to calculate due to limited data
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Net profit margin is responsible for roe increase over last 10 years
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Share price

Share price has increased over last 10 years but more due to rerating
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Centuple Global Ltd. Business

What does Centuple Global do?

Rubra Medicaments Ltd, established in 1991, is engaged in the non-specialized wholesale trade, focusing on traded goods.

Who are the competitors of Centuple Global?

Centuple Global major competitors are Scarnose Internatl., Sarthak Inds, Aspire & Innovative, Shrenik, Standard Batteries, Asian Tea & Exports, Dalmia Indl. Dev.
Market Cap of Centuple Global is ₹24 Crs.
While the median market cap of its peers are ₹24 Crs.

Is Centuple Global financially stable compared to its competitors?

Centuple Global seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Company Filing

	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Claude

Discussions & Analysis

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Centuple Global Ltd.

Centuple Global Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

8 Yes

2 Neutral

5 No

2 No Data

Accounting & Shareholding

Depreciation Effect

Other Income

Pledge

Promoter Holding

Retail Holding

Revenue Recognition

Contingent Liabilities

Price & Performance

Capex vs ROCE

ROE

Current vs Historic Valuation

Debt

Sales Growth

Balance Sheet Strength

Share price

Working Capital

Margin Stability

ROCE Strength

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Peer Comparison

FAQs on Centuple Global Ltd. Business

What does Centuple Global do?

Who are the competitors of Centuple Global?

Is Centuple Global financially stable compared to its competitors?

Company Filing

Discussions & Analysis

SIGN UP FOR FREE